SAFElife T-Dip Multi-Drug Urine Test Panel; SAFElife T-Dip Multi-Drug Urine Test Panel Dx— 510(k) K260065

Substantially Equivalent

Guangzhou Wondfo Biotech Co., Ltd.

FDA 510(k) clearance K260065 for SAFElife T-Dip Multi-Drug Urine Test Panel; SAFElife T-Dip Multi-Drug Urine Test Panel Dx, Substantially Equivalent on 2026-04-28. Applicant: Guangzhou Wondfo Biotech Co., Ltd.. Device class: 2.

Summary

Guangzhou Wondfo Biotech's record names two products: the SAFElife T-Dip Multi-Drug Urine Test Panel and the SAFElife T-Dip Multi-Drug Urine Test Panel Dx. Both are filed under product code NFT (Test, Amphetamine, Over The Counter), and the record doesn't say how the two differ.

Class II, 21 CFR 862.3100. It came in as a Traditional 510(k), and Clinical Toxicology is both the classification panel and the review panel.

Guangzhou Wondfo Biotech filed from Guangzhou, China. Review took 109 calendar days (January 9 to April 28, 2026).

Clearance details

Applicant
Guangzhou Wondfo Biotech Co., Ltd.
Product code
Product code NFT
Device class
Class 2
Regulation
21 CFR 862.3100
Advisory panel
Clinical Toxicology
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Guangzhou, CN
Download summary PDFView on FDA.gov ↗

Recent devices under product code NFT

view all

More clearances from Guangzhou Wondfo Biotech Co., Ltd.

view all

Data sourced from openFDA. This site is unofficial and independent of the FDA.